Trevi Therapeutics, Inc.

NASDAQ:TRVI

7.06 (USD) • At close June 6, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q4
Omzet 000000.176000000000000000000000000
Kosten van de omzet 0000.0380.0350.0350.0350.0340.0190.0150.0090.0080.0110.0120.0130.0120.0130000000000000
Brutowinst 000-0.038-0.0350.141-0.035-0.034-0.019-0.015-0.009-0.008-0.011-0.012-0.013-0.012-0.0130000000000000
Brutowinstmarge 000000.801000000000000000000000000
Onderzoek- en ontwikkelingskosten 7.8119.32811.22410.0218.8046.5186.3235.84254.3175.7695.1034.6456.1794.7186.4985.5896.564.8284.9216.0194.8235.655.5283.3384.5233.7473.4392.3631.598
Algemene en administratieve kosten 3.6592.9152.8633.2683.1022.4152.7222.542.5632.3392.6362.7172.382.0942.2292.6692.52.6332.4162.4922.621.94321.8891.4741.4061.210.9410.7790.611
Verkoop- en marketingkosten 000-0.038-0.035-0.035000000000000000000000000.013
Verkoop-, algemene en administratieve kosten 3.6592.9152.8633.233.0672.382.7222.542.5632.3392.6362.7172.382.0942.2292.6692.52.6332.4162.4922.621.94321.8891.4741.4061.210.9410.7790.624
Overige kosten 000-0.005-0.001-0.0030.1540.1531.1551.13200000-0.3750-0.3130000.22500.066-0.052-0.148-0.749-0.49-0.8560
Bedrijfskosten 11.4712.24314.08713.25111.8718.8989.0458.3827.5636.6568.4057.827.0258.2736.9479.1678.0899.1937.2447.4138.6396.7667.657.4174.8125.9294.9574.383.1422.232
Bedrijfsresultaat -11.47-12.243-14.087-13.289-11.906-8.933-9.045-8.382-7.563-6.656-8.405-7.82-7.025-8.273-6.947-9.167-8.089-9.193-7.244-7.413-8.639-6.766-7.65-7.417-4.812-5.929-4.957-4.38-3.142-2.222
Bedrijfsresultaat ratio 00000-50.756000000000000000000000000
Totaal overige inkomsten en kosten netto 1.1190.8440.8140.9290.9961.131.3341.2071.1551.1320.132-0.236-0.309-0.253-0.306-0.629-0.297-0.313-0.1450.0140.1570.2250.280.0660.006-0.102-0.722-0.503-0.934-0.164
Inkomen voor belasting -10.351-11.399-13.273-12.36-10.91-7.803-7.711-7.175-6.408-5.524-8.273-8.056-7.334-8.526-7.253-9.796-8.386-9.506-7.389-7.399-8.482-6.541-7.37-7.351-4.806-6.031-5.679-4.883-4.076-2.386
Inkomen voor belasting ratio 00000-44.335000000000000000000000000
Belastingkosten -0.0110.016-0.031-0.008-0.0080.018-0.013-0.03-0.007-0.02-0.007-0.004-0.005-0.0060.002-0.002-0.0150.017-0.011-0.015-0.009-0.004-0.005-0.005-0.004-0.049-0.025-0.025-0.0250.008
Nettowinst -10.34-11.415-13.242-12.352-10.902-7.821-7.698-7.145-6.401-5.504-8.266-8.052-7.329-8.52-7.255-9.794-8.371-9.523-7.378-7.384-8.473-6.537-7.365-7.346-4.802-5.982-5.654-4.858-4.051-3.485
Nettowinstmarge 00000-44.438000000000000000000000000
WPA (Winst Per Aandeel) -0.09-0.11-0.13-0.12-0.11-0.079-0.078-0.072-0.065-0.056-0.12-0.14-0.24-0.39-0.34-0.49-0.43-0.51-0.41-0.41-0.48-0.37-0.41-0.41-0.27-0.34-0.63-0.54-0.45-0.28
Verwaterde WPA -0.09-0.11-0.13-0.12-0.11-0.079-0.078-0.072-0.065-0.056-0.12-0.14-0.24-0.39-0.34-0.49-0.43-0.51-0.41-0.41-0.48-0.37-0.41-0.41-0.27-0.34-0.63-0.54-0.45-0.28
EBITDA -11.47-11.36-13.236-12.321-10.874-7.764-7.673-6.988-6.158-5.236-7.972-7.753-7.021-8.205-6.937-9.488-8.079-9.185-7.228-7.388-8.472-6.532-7.359-7.407-4.803-6.018-5.675-4.376-3.951-2.221
EBITDA ratio 00000-44.114000000000000000000000000